Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000895421-25-000475·Jasper Therapeutics, Inc.
Schedule 13G ownership disclosure
JASPER THERAPEUTICS INC
Voting Common Stock · CUSIP: 471871202
Event date: 2025-06-30
- Filing-level shares
- 758,453
- Percent of class
- 5.0%
- Morgan Stanley
Shares: 758,453 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000475
- Form type
- SCHEDULE 13G
- Filer
- Jasper Therapeutics, Inc.
- CIK
- CIK 1788028
- Filed
- Aug 06, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership